|
2024
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Providing medical information |
|
|
G/S
|
Pharmaceutical preparations for use in oncology and to treat
the abnormal growth of both benign ... |
|
|
G/S
|
Pharmaceutical preparations; human vaccine preparations. Providing medical information. |
|
|
G/S
|
Pharmaceutical preparations; human vaccine preparations. |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
2023
|
Invention
|
Combination therapies for treating cancer.
The present invention provides methods of treatment f... |
|
2022
|
Invention
|
4-imidazopyridazin-1-yl-benzamides as btk inhibitors.
The present invention relates to 6-5 membe... |
|
2021
|
Invention
|
Combination therapy of a pd-1 antagonist and an antagonist for vegfr-2 for treating patients with... |
|
|
Invention
|
Kit for and method of assembling an applicator for inserting an implant.
The invention pertains ... |
|
2020
|
Invention
|
Combination therapy with liv1-adc and pd-1 antagonist.
The present disclosure relates, in genera... |
|
|
Invention
|
Combination therapy with liv1-adc and pd-1 antagonist. The present disclosure relates, in general... |
|
|
Invention
|
Belantamab mafodotin in combination with pembrolizumab for treating cancer.
Disclosed herein are... |
|
|
Invention
|
Belantamab mafodotin in combination with pembrolizumab for treating cancer. Disclosed herein are ... |
|
2019
|
Invention
|
Apparatus and method for preserving mucosa. A mixing apparatus (1) for mixing slaughter offal wit... |
|
|
Invention
|
4-imidazopyridazin-1-yl-benzamides as btk inhibitors. The present invention relates to 6-5 member... |
|
2018
|
Invention
|
Kit for and method of assembling an applicator for inserting an implant. The invention pertains t... |
|
|
Invention
|
Combination therapies for treating cancer. The present invention provides methods of treatment fo... |
|
|
Invention
|
Formulation for parenteral administration. The instant invention provides pharmaceutical formulat... |
|
2017
|
Invention
|
Anti-cd27 antibodies.
The present invention relates to anti-CD27 antibodies, as well as use anti... |
|
|
Invention
|
Anti-cd27 antibodies. The present invention relates to anti-CD27 antibodies, as well as use antib... |
|
|
Invention
|
Anti-cd27 antibodies. The present invention relates to anti-CD27 antibodies, as well as use of th... |
|
2016
|
Invention
|
Backstop for a syringe.
A backstop for a syringe can include a base having a first surface and a... |
|
|
Invention
|
Backstop for a syringe. A backstop for a syringe includes a base having a first surface and an op... |
|
|
Invention
|
Btk inhibitors.
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compound... |
|
|
Invention
|
Btk inhibitors. The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds... |
|
|
Invention
|
Vaginal ring applicator. A vaginal ring applicator having a polymeric barrel and at least one fri... |
|
|
Invention
|
Vaginal ring applicator. Described herein is a vaginal ring applicator comprising a barrel compri... |
|
|
Invention
|
Apparatus and method for preserving mucosa.
A mixing apparatus (1) for mixing slaughter offal wi... |
|
|
Invention
|
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk inhibitors. The pr... |
|
2015
|
Invention
|
Crystal forms of a ccr5 antagonist. The present disclosure relates to forms of a CCR5 inhibitory ... |
|
|
Invention
|
Intrauterine deposit.
An intrauterine system for the retention of a biologically active compound... |
|
|
Invention
|
Fsh receptor antagonists. The invention relates to FSH receptor antagonist according to general f... |
|
|
Invention
|
Mk2 inhibitors.
The present invention relates to compounds of general Formula I
The present in... |
|
|
Invention
|
Stable formulations of testosterone undecanoate. The present invention is directed to stable phar... |
|
|
Invention
|
A method to dry multiple individual frozen bodies and a system for applying this method. The pres... |
|
2014
|
Invention
|
Antibodies to human programmed death receptor pd-1. Antibodies which block binding of hPD-1 to hP... |
|
|
Invention
|
Drug delivery system for delivery of anti-virals. Described herein is a vaginal ring drug deliver... |
|
|
Invention
|
Drug delivery system. Described herein is an intra-vaginal drug delivery system comprising (i) a ... |
|
|
Invention
|
Drug delivery system.. Described herein is an intra-vaginal drug delivery system comprising (i) a... |
|
|
Invention
|
Pharmaceutical formulation comprising losartan potassium and chlorthalidone. The invention is a p... |
|
2011
|
Invention
|
N-substituted azetidine derivatives. The present invention relates to novel N-substituted azetidi... |
